coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Trafford West PCN, Trafford (LAD) · Health Inequalities Profile

    PCN U79881 · NHS Greater Manchester Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    53,655

    Registered population

    59.1% aged 18–64

    20.5%

    Aged 65+

    ICB 14.9% · England 17.9%

    7.7%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~3,514

    Core20 residents (est.)

    Resident basis; registered basis ~4,144 · see page 3

    9,115

    Hypertension register

    +2.15% in 3 yrs · England +5.60%

    566

    SMI register

    21.1% of Trafford (LAD)'s

    1,583

    COPD register

    Reviews -1.33% in 3 yrs

    Forecast to 2030

    9,673

    Hypertension patients, 2030

    +558 on today

    74.8%

    QRISK ≥20% on statins, 2030

    +2.60pp over 3 yrs

    5.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    56.4%
    Asthma annual reviews fall behind national coverage.

    Annual review coverage is 56.4% (England 65.7%) after a -8.7% three-year change (England +4.4%), leaving an estimated 1,945 unreviewed patients, which may reflect recall.

    69.4%
    Heart failure review coverage trails all comparators.

    Coverage across 810 registered patients is 69.4% (Trafford 76.6%, ICB 80.0%, England 78.5%) following a -4.1% three-year change, which could reflect appointment capacity.

    83.8%
    Strong blood pressure and diabetes biometric control.

    Hypertension control aged 80+ reached 83.8% (England 81.2%, up +5.4% over three years), alongside 58.6% HbA1c control in non-frail diabetes (England 57.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Registered patients aged 65+ reach 20.5%, exceeding borough, regional and England averages

    Trafford West PCN comprises 53,655 registered patients across member practices, using GP-registered population bases. The PCN is older than benchmarks: 20.5% (11,004 patients) are aged 65+, compared with 17.1% in Trafford (LAD), 14.9% in NHS Greater Manchester Integrated Care Board, and 17.9% in England. Working-age adults aged 18-64 make up 59.1% (31,689 patients; LAD 61.0%, ICB 63.3%, England 62.7%), while children aged 0-17 represent 20.4% (10,962 patients; LAD 21.8%, ICB 21.8%, England 19.6%), concentrating in Partington Family Practice (25.6%) and Partington Central Surgery (25.0%). Recorded Gypsy or Irish Traveller and Roma groups are each 0.0%.

    Age profile

    0–1720.4%
    18–6459.1%
    65+20.5%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Trafford (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Trafford LA)2,0872,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.0%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Trafford LA)9501,0219552024/25
    Falls deaths, all ages, per 100,000 (Trafford LA)22.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is moderate overall but concentrated entirely within two Partington practices

    Trafford West PCN's Core20 share is 7.7%, below England (21.0%), Trafford (8.2%) and NHS Greater Manchester ICB (40.7%). Deprivation is concentrated in two practices: Partington Central Surgery has the highest concentration (40.6%; 1,603 estimated patients), while Partington Family Practice carries the largest volume (2,541 estimated patients; 37.8%). The other four practices record 0.0%. The discrepancy between resident Core20 estimates (3,514) and practice-level modelled counts (4,144) is consistent with differing population bases.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Partington40.6% · 1,603 patients
    Partington37.8% · 2,541 patients
    Urmston0.0% · 0 patients
    Davyhulme0.0% · 0 patients
    Primrose0.0% · 0 patients
    Flixton Road0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    566

    SMI register

    1.05% recorded prevalence

    383

    Learning disability register

    0.71% recorded prevalence

    21

    Care homes, 531 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Trafford (LAD), Census 2021

    Recorded learning disability prevalence is 0.7% (383 patients), above Trafford (LAD 0.5%), NHS Greater Manchester Integrated Care Board (0.6%), and England (0.6%). Severe mental illness prevalence is 1.1% (566 patients; Trafford (LAD) 1.1%, NHS Greater Manchester Integrated Care Board 1.1%, England 1.0%). The PCN catchment includes 21 care homes with 531 beds.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 86.9% (England 83.4%) with three-year change of +0.4 pp (England +4.4 pp), while BMI recording reached 86.9% (England 82.1%). Multi-element physical reviews require systematic recall to prevent monitoring from stagnating.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,115

    Hypertension register

    +2.15%

    Register growth, 3 yrs

    Trafford (LAD) +4.39% · England +5.60%

    +3.88pp

    BP control, under 80

    ≤140/90 · +4.29pp aged 80+

    +558

    More patients by 2030

    Forecast 9,673 (17.69%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 17.0% (9,115 patients), above England (15.2%), Trafford (15.1%), and NHS Greater Manchester ICB (14.4%), though three-year register growth was +2.1% against +5.6% nationally. Treatment to target reached 71.1% (England 70.3%), with 67.7% controlled under age 80 (England 67.8%) and 83.8% aged 80+ (England 81.2%), while 90.1% had a recent blood pressure check. However, annual review coverage for 810 heart failure patients fell 4.1% over three years (England +8.7%) to 69.4%, trailing England (78.5%), Trafford (76.6%), and the ICB (80.0%). Heart failure review coverage sits notably below all comparators despite strong blood pressure control, indicating that post-diagnostic cardiovascular recall warrants prioritisation.

    Lipids and statins

    Lipid-lowering therapy reaches 69.3% of patients with QRISK ≥ 20% (England 63.6%) and 74.4% with CKD (England 70.3%). In diabetes with CVD, statin coverage is 84.5% (England 84.4%), but fell 0.8% over three years (England +1.0%). Slipping statin coverage in diabetic CVD points to a recall opportunity for high-risk secondary prevention.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026133,811£1.90£1.94£1.86£254,241
    Cardiovascular (all), 2025182,855£2.67£3.15£3.33£488,223

    In 2026, the PCN prescribed 133,811 lipid-regulating drug items at £1.90 per item (England £1.86, Trafford £1.98, NHS Greater Manchester ICB £1.94). This spend is £5,352 more than at England's unit cost across 133,811 items, though unit cost does not measure efficiency or clinical case-mix.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −8.73%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.71%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 8.8% (Trafford 7.3%, England 6.6%) across 4,457 registered patients, alongside youth prescribing of 2,163 items per 1000 population aged 5-19 (England 1,488). However, annual asthma reviews fell 8.7% over three years (England +4.4%) to 56.4% (England 65.7%), leaving an estimated scale gap of 1,945 unreviewed patients. COPD prevalence is 2.9% (1,583 patients; England 1.9%) with review coverage at 77.6% (England 76.4%). Prioritising proactive asthma recall could address this substantial review shortfall.

    Cancer register and children's immunisation

    Cancer recorded prevalence is 4.7% across 2,538 registered patients (England 3.8%). In childhood immunisations, 6-in-1 coverage at 12 months is 88.9% (England 91.0%). At age five, MMR first-dose coverage reached 95.2% while second-dose coverage is 88.3%, a 6.9 pp dose difference between first and second dose coverage in the same cohort. Targeted pre-school recall could help close the second-dose immunisation gap.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months88.9%

    England 91.0%

    6-in-1 complete primary course at 24 months94.2%

    England 92.2%

    MMR dose 1 at 24 months91.3%

    England 88.3%

    MMR dose 2 at age 588.3%

    England 82.8%

    4-in-1 pre-school booster at age 586.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of known-stage cancers in NHS Greater Manchester ICB (6,491 of 11,679) were diagnosed at stage 1 or 2, above England (55.3%) but 19.4 percentage points below the 75.0% national ambition by 2028 (a scale gap of 2,268.2 early cases). Staged completeness was 70.8% (11,679 of 16,492). Early-stage shares ranged from 22.4% for oesophagus (77 of 344) to 82.5% for breast (1,451 of 1,758). Staging reflects wider system performance, not PCN delivery. Within the PCN, cervical screening coverage (25-49 years) was 74.4%, while Partington Central Surgery recorded 63.5%. Addressing screening variation across member practices provides a local preventative focus alongside broader system pathways.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Manchester University NHS Foundation Trust met the 28-day faster diagnosis standard at 80.1%, ahead of Northern Care Alliance NHS Foundation Trust (75.2%), the ICB (79.5%) and England (79.3%), but behind Bolton NHS Foundation Trust (80.5%). However, its 62-day referral to treatment performance was 72.8%, trailing the 85.0% standard, Northern Care Alliance NHS Foundation Trust (78.6%) and the ICB (75.7%), though above England (71.2%) and Bolton NHS Foundation Trust (69.7%). Patients waiting 6+ weeks for diagnostics reached 11.7% for MRI and 13.0% for cystoscopy. Provider treatment backlogs mean referred patients face delays reaching definitive first treatment.

    Pathways within standard (%)ManchesterNorthern Care AllianceBoltonGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0675.2080.4879.5379.32
    31-day treatment (96%)92.5494.5496.5096.4992.50
    62-day referral to treatment (85%)72.8578.6569.6675.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterNorthern Care AllianceBoltonEngland
    MRI11.685.092.0521.40
    CT14.664.1019.409.92
    Echocardiography4.9131.483.4828.48
    Colonoscopy4.5140.041.3330.83
    Gastroscopy29.3536.482.0629.02
    All 15 DM01 tests8.9815.7115.7823.14
    Community services activityTrafford residentsGreater Manchester ICB
    Care contacts41,705573,310
    Referrals7,44594,470
    Patients with a contact13,840183,535

    Community services (residents of Trafford), Jun 2026 (provisional). In June 2026, 51.3% of community service contacts for Trafford residents (21,375 of 41,705) were for adults aged 65 and over. These provisional figures represent borough resident activity rather than PCN delivery. With 20.5% of PCN patients aged 65+, primary care may experience high shared demand with community nursing teams.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    QOF vaccination achievement spans 58.0 percentage points across member practices

    In 2025/26, overall QOF achievement ranged from 77.5% at Partington Central Surgery to 97.7% at Urmston Group Practice (England 92.5%). Vaccination and immunisation achievement spanned 58.0 pp, from 24.5% at Flixton Road Medical Centre to 82.5% at Urmston Group Practice (England 55.2%). Checking clinical coverage and personalised care adjustments would test whether point shortfalls reflect delivery gaps.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Davyhulme1220.069.2%77.6%86.7%
    Primrose Surgery1220.082.4%59.5%83.2%
    Flixton Road1140.070.5%71.3%80.7%
    Urmston1110.051.5%70.1%80.2%
    Partington12037.865.4%74.6%78.3%
    Partington8240.662.0%69.9%63.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNTrafford (LAD)AssetPCNTrafford (LAD)
    Care homes (catchment)21 (531 beds)n/aSchools (catchment)51n/a
    Children's centres416Places of worship25119
    Libraries29Primary schools (LA maintained)639
    Primary academies817Special schools13

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Proactive asthma annual review recall

    Asthma annual review coverage is 56.4% across 4,457 registered patients, below England (65.7%) by 9.3 pp and Trafford (63.7%) by 7.3 pp, leaving an estimated scale gap of 1,945 unreviewed patients. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Heart failure review and functional assessment

    Heart failure annual review coverage is 69.4% across 810 registered patients, below England (78.5%) by 9.2 pp, Trafford (76.6%) by 7.2 pp, and the ICB (80.0%) by 10.6 pp. For discussion: practices could establish a proactive recall list for heart failure reviews including functional capacity assessment, starting in high-deprivation practices. Moderate effort to run.

    Option 3

    Standardised SMI physical health check recall

    SMI blood pressure check recording across 566 registered patients changed by +0.4 pp from 2023 to 2025, a difference of -4.0 percentage points compared with England (+4.4 pp) and -4.6 percentage points compared with Trafford (+5.0 pp), though the current rate is 3.5 percentage points above England. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted Partington Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Systematic SMI physical health recall (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Heart failure annual review recall (p5)Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs)—PCN
    Pre-school MMR booster catch-up (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Option 1 · Proactive asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Heart failure review and functional assessment (p12)Heart failure register · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs)—PCN
    Option 3 · Standardised SMI physical health check recall (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15